Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clinical benefit

Impetus Digital Fireside Chat with Esther Schorr from Patient Power LLC

Esther Schorr, Co-founder and Chief Operating Officer of Patient Power, discusses her non-linear journey to patient education and Patient Power's mission to empower patients and their loved ones to take control...

Impetus Digital

- PMLiVE

OPEN Health’s latest partnership with Rare Revolution Magazine

Richard Jones introduces our Head of Health Psychology (Dr Sumira Riaz)

OPEN Health

Patient-Owned Online Marketplace for Patient Insights

Jen Horonjeff, Founder & CEO of Savvy Cooperative, talks about how her personal health journey and experience as a chronic disease patient lead to her founding Savvy Cooperative. We also discuss...

Impetus Digital

Perspective: the patient edition

In this issue of Perspective magazine, we explore how the industry can place a greater emphasis on patient-centricity, and how pharmaceutical companies are working with patients across the product lifecycle...

Blue Latitude Health

- PMLiVE

Mapping the patient journey and minding the gap

Seven steps to closing the gap between rhetoric and reality in patient-centricity

Lighthouse Medical Communications US – An opportunity of a lifetime to be part of the Lucid Group magic

Our family at Lighthouse Medical Communications US are looking for talented individuals to join its team in hashtagManhattan. If you want to be part of something magical get in touch...

Lucid Group Communications Limited

Patient journey mapping: exploring the clinical and the emotional journey

By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew

It’s the guns, stupid

Gun violence in the US – a public health issue – can be better understood through three points

- PMLiVE

Envision Pharma Group relocates to support expansion

Office moves in the US prompted by significant growth

- PMLiVE

How can we realise the benefits of patient engagement?

By Stephen O’Farrell and Nadine van Dongen

- PMLiVE

Amgen reveals more data on KRAS drug

Unveiled an overall disease control rate of 100%

Novartis day

Novartis close to US bribery settlement

Company faces huge damages pay out

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links